Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| VITAMIN D3 | Jamp Pharma Corporation | Marketed | Apr 30, 2024 | Marketed |
| MINT-FAMOTIDINE | mint pharmaceuticals inc | Marketed | Apr 30, 2024 | Marketed |
| SANDOZ RIOCIGUAT | Sandoz Canada, Inc. | Marketed | Apr 29, 2024 | Marketed |
| SANDOZ RIOCIGUAT | Sandoz Canada, Inc. | Marketed | Apr 29, 2024 | Marketed |
| SILDENAFIL | sivem pharmaceuticals ulc | Marketed | Apr 29, 2024 | Marketed |
| SILDENAFIL | sivem pharmaceuticals ulc | Marketed | Apr 29, 2024 | Marketed |
| SUMATRIPTAN | sivem pharmaceuticals ulc | Marketed | Apr 29, 2024 | Marketed |
| IMATINIB | sivem pharmaceuticals ulc | Marketed | Apr 29, 2024 | Marketed |
| SANDOZ RIOCIGUAT | Sandoz Canada, Inc. | Marketed | Apr 29, 2024 | Marketed |
| SANDOZ RIOCIGUAT | Sandoz Canada, Inc. | Marketed | Apr 29, 2024 | Marketed |
| SILDENAFIL | sivem pharmaceuticals ulc | Marketed | Apr 29, 2024 | Marketed |
| SUMATRIPTAN | sivem pharmaceuticals ulc | Marketed | Apr 29, 2024 | Marketed |
| SANDOZ AMOXICILLIN | Sandoz Canada, Inc. | Marketed | Apr 29, 2024 | Marketed |
| IMATINIB | sivem pharmaceuticals ulc | Marketed | Apr 29, 2024 | Marketed |
| SANDOZ RIOCIGUAT | Sandoz Canada, Inc. | Marketed | Apr 29, 2024 | Marketed |
| M-METHOTREXATE | mantra pharma inc | Marketed | Apr 24, 2024 | Marketed |
| AG-TRAZODONE | angita pharma inc. | Marketed | Apr 23, 2024 | Marketed |
| AG-TRAZODONE | angita pharma inc. | Marketed | Apr 23, 2024 | Marketed |
| AG-TRAZODONE | angita pharma inc. | Marketed | Apr 23, 2024 | Marketed |
| M-DIENOGEST | mantra pharma inc | Marketed | Apr 23, 2024 | Marketed |
